Dr. Mohammad Ghassemi—an internationally renowned data scientist and independent AI expert—joins us to discuss best practices for creating AI products that drive business impact.

Innovation expert Stephen Wunker of New Markets Advisors joins us to discuss how companies can unlock the benefits of generative AI.

Stephen Wunker and Charlotte Desprat of New Markets Advisors join us to discuss FutureCasting, a rigorous, four-step process to help organizations prepare for all types of uncertainty.

Upwork's Eric Gilpin and BTG's Jody Greenstone Miller discuss independent talent trends, how companies can address their biggest opportunities, and predictions for the on-demand talent market.

BTG Chief Knowledge and Innovation Officer Sandra Pinnavaia joins us to discuss a few of the biggest leadership and resourcing trends shaping organizations today.

Senior IT consultant, executive, and blockchain expert Peter Wokwicz joins us to discuss a few of the biggest trends in enterprise blockchain, cryptocurrency, and decentralized finance.

Diversity, equity, and inclusion expert Todd Corley shares his advice on how leading companies can build and advance D&I initiatives and implement change that improves the well being of all people.

Logitech's David Latten, Head of Global Indirect Procurement, joined us to discuss how on-demand talent helps the company complete critical work, bring expertise in-house, and do more with less.

NASA’s Center of Excellence for Collaborative Innovation (CoECI) Deputy Director Steve Rader discusses why open innovation platforms are a powerful tool for problem-solving across the U.S. government.

Microsoft’s Freelance Services Program is a great example of how enterprises can tap the gig economy to get work done. Program manager Nihat Sengul joins us to discuss his role in ensuring its success

John O'Hara, VP of Strategic Initiatives at Janssen, joins us to discuss J&J's framework for ethical decision-making in pharma manufacturing and supply chain related to the COVID-19 pandemic

Commercial strategy leaders must prepare now to ensure success for potential COVID-19 treatments. Biopharma expert Marc Cooley shares what life science companies should keep in mind at this moment.

COVID-19 is sidelining the field reps that life science companies rely on for in-person pharmaceutical detailing. Healthcare marketing strategist Martine Taylor discusses how eDetailing can help.

Sandy Torrekens—Lead Strategist for the UK Dept. of Health during the “Swine Flu” pandemic—joins us to discuss how life science and pharma companies can respond to COVID-19 supply chain disruption.

Global supply chains are severely strained by the coronavirus (COVID-19) pandemic. Supply chain and manufacturing specialist Rosemary Coates discusses how companies can address the disruption.

Continuity expert Kathleen McGrorty joins us to discuss how executives can mitigate risk, create resilient business models, and protect operations in the face of the coronavirus (COVID-19) pandemic.

Innovation expert Steve Wunker joins BTG's Leah Hoffmann to discuss how companies can adapt business strategies to the coronavirus (COVID-19) pandemic and all the upheaval that it has brought.

George Post recently retired as the Director of World Headquarters Procurement at life science giant Johnson & Johnson.There, as part of his broader mission to optimize procurement and consulting...